Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmaPrint

This article was originally published in The Tan Sheet

Executive Summary

Six vitamin/herbal combination products to be distributed by online superstore Value America under a recent agreement between the firms. PharmaPrint and Charlottesville, Va.-based Value America will co-promote the new line, marketed under the PharmaPrint label, through major media outlets. Value America is PharmaPrint's second e-commerce partner; the Irvine, Calif.-based supplement manufacturer previously announced a distribution agreement with healthzone.com (1"The Tan Sheet" Sept. 6, p. 11). PharmaPrint also names Richard Piazza as new president and CEO. Piazza is the former CEO of VitaGen, a biotech company specializing in combating liver disease. He replaces Elliot Friedman, who remains as full-time chairman

You may also be interested in...



PharmaPrint

Steven Bowman tapped interim CEO, filling in until a replacement is found for Richard Piazza, the company announces May 11. Piazza stepped down from the president, CEO and chairman of the board positions he assumed last November from Elliot Friedman, who remains a board member (1"The Tan Sheet" Oct. 18, 1999, p. 20). Former PharmaPrint corporate counsel and board member Phil Trad temporarily assumed the responsibilities of president, treasurer and company secretary; the board remains without a chairman. Although a search is underway, PharmaPrint says restructuring debt and shoring up the firm's finances are more pressing priorities than recruiting a president or permanent replacements for the other positions (2"The Tan Sheet" Feb. 28, p. 8)

PharmaPrint

Steven Bowman tapped interim CEO, filling in until a replacement is found for Richard Piazza, the company announces May 11. Piazza stepped down from the president, CEO and chairman of the board positions he assumed last November from Elliot Friedman, who remains a board member (1"The Tan Sheet" Oct. 18, 1999, p. 20). Former PharmaPrint corporate counsel and board member Phil Trad temporarily assumed the responsibilities of president, treasurer and company secretary; the board remains without a chairman. Although a search is underway, PharmaPrint says restructuring debt and shoring up the firm's finances are more pressing priorities than recruiting a president or permanent replacements for the other positions (2"The Tan Sheet" Feb. 28, p. 8)

PharmaPrint

Steven Bowman tapped interim CEO, filling in until a replacement is found for Richard Piazza, the company announces May 11. Piazza stepped down from the president, CEO and chairman of the board positions he assumed last November from Elliot Friedman, who remains a board member (1"The Tan Sheet" Oct. 18, 1999, p. 20). Former PharmaPrint corporate counsel and board member Phil Trad temporarily assumed the responsibilities of president, treasurer and company secretary; the board remains without a chairman. Although a search is underway, PharmaPrint says restructuring debt and shoring up the firm's finances are more pressing priorities than recruiting a president or permanent replacements for the other positions (2"The Tan Sheet" Feb. 28, p. 8)

Related Content

Topics

UsernamePublicRestriction

Register

PS090451

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel